NathanAPennellMDPhD, FASCO

PubMed

• Lessons from ADAURA: Can we improve on a positive trial?
  Howard Jack West, Nathan A Pennell> ;Cancer. 2024 Mar 1
• ADAURA update: only the end of the beginning.
  Bharathi Muthusamy, Nathan A Pennell> ;Translational Lung Cancer Research. 2023 Jul 31
• Clinical Nomogram Using Novel Computed Tomography-Based Radiomics Predicts Survival in Patients With Non-Small-Cell Lung Cancer Treated With Stereotactic Body Radiatio...
  Eashwar Somasundaram, Raoul R Wadhwa, Adam Litzler, Rowan Barker-Clarke, Peng Qi, Gregory Videtic, Kevin Stephans, Nathan A Pennell, Daniel Raymond, Kailin Yang, Micha...> ;JCO Clinical Cancer Informatics. 2023 Jun 1
• 13 citations
  Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer.
  Arvind Ravi, Matthew D Hellmann, Monica B Arniella, Mark Holton, Samuel S Freeman, Vivek Naranbhai, Chip Stewart, Ignaty Leshchiner, Jaegil Kim, Yo Akiyama, Aaron T Gr...> ;Nature Genetics. 2023 May 1
• 2 citations
  Clinical Outcomes With Pembrolizumab-Based Therapies in Recurrent/Refractory NSCLC After Chemoradiation and Consolidative Durvalumab.
  Lukas Delasos, Wei Wei, Khaled A Hassan, Nathan A Pennell, Pradnya Patil, James Stevenson> ;Clinical Lung Cancer. 2023 Sep 1
• 1 citations
  TRUST-II: a global phase II study of taletrectinib in-positive non-small-cell lung cancer and other solid tumors.
  Misako Nagasaka, Yuichiro Ohe, Caicun Zhou, Chang-Min Choi, Nong Yang, Geoffrey Liu, Enriqueta Felip, Maurice Pérol, Benjamin Besse, Jorge Nieva, Luis Raez, Nathan A P...> ;Future Oncology. 2023 Jan 1
• 1 citations
  Modeling Costs and Life-Years Gained by Population-Wide Next-Generation Sequencing or Single-Gene Testing in Nonsquamous Non-Small-Cell Lung Cancer in the United States.
  Christopher A Lemmon, Jie Zhou, Brian Hobbs, Nathan A Pennell> ;JCO Precision Oncology. 2023 Jan 1
• 5 citations
  Quantifying the Value of Multigene Testing in Resected Early Stage Lung Adenocarcinoma.
  Bharathi Muthusamy, Kira Raskina, Katherine T Lofgren, Gerald Li, Khaled Tolba, Karen Schwed, Emily Castellanos, Richard S P Huang, Geoffrey R Oxnard, Alexa B Schrock,...> ;Journal of Thoracic Oncology. 2023 Apr 1
• 11 citations
  Perioperative Systemic Therapy for Resectable Non-Small Cell Lung Cancer.
  Bharathi Muthusamy, Pradnya D Patil, Nathan A Pennell> ;Journal of the National Comprehensive Cancer Network. 2022 Aug 1
• 13 citations
  The Rise of the Expert Patient in Cancer: From Backseat Passenger to Co-navigator.
  Andrea Anampa-Guzmán, Janet Freeman-Daily, Michael Fisch, Emil Lou, Nathan A Pennell, Corrie A Painter, Dorinda Sparacio, Mark A Lewis, Maimah Karmo, Patricia F Anders...> ;JCO Oncology Practice. 2022 Aug 1
• 194 citations
  Adagrasib in Non-Small-Cell Lung Cancer Harboring aMutation.
  Pasi A Jänne, Gregory J Riely, Shirish M Gadgeel, Rebecca S Heist, Sai-Hong I Ou, Jose M Pacheco, Melissa L Johnson, Joshua K Sabari, Konstantinos Leventakos, Edwin Ya...> ;The New England Journal of Medicine. 2022 Jul 14
• 6 citations
  A Phase 1 Study of Concurrent Neoadjuvant Pembrolizumab Plus Chemoradiation Followed by Consolidation Pembrolizumab in Patients With Resectable Stage IIIA NSCLC.
  Christopher A Lemmon, Gregory M M Videtic, Sudish Murthy, Kevin L Stephans, Marc Shapiro, Usman Ahmad, Daniel Raymond, Vamsidhar Velcheti, Alejandro Bribriesco, Xuefei...> ;JTO Clinical and Research Reports. 2022 Jul 1
• Impact of Socioeconomic Factors on Overall Survival in SCLC.
  Logan Roof, Wei Wei, Katherine Tullio, Nathan A Pennell, James P Stevenson> ;JTO Clinical and Research Reports. 2022 Jul 1
• 1 citations
  A Review of Concurrent Chemo/Radiation, Immunotherapy, Radiation Planning, and Biomarkers for Locally Advanced Non-small Cell Lung Cancer and Their Role in the Develop...
  John Michael Varlotto, Zhuoxin Sun, Bonnie Ky, Jenica Upshaw, Thomas J Fitzgerald, Max Diehn, Christine Lovly, Chandra Belani, Kurt Oettel, Gregory Masters, Matthew Ha...> ;Clinical Lung Cancer. 2022 Nov 1
• 3 citations
  Novel Radiomic Measurements of Tumor-Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple Cancers.
  Nathaniel Braman, Prateek Prasanna, Kaustav Bera, Mehdi Alilou, Mohammadhadi Khorrami, Patrick Leo, Maryam Etesami, Manasa Vulchi, Paulette Turk, Amit Gupta, Prantesh ...> ;Clinical Cancer Research. 2022 Oct 14
• 2 citations
  Strategies and End Points in the Development of Novel Immunotherapy Trials for Patients With Unresectable, Locally Advanced Non-Small-Cell Lung Cancer.
  Nathan A Pennell> ;Journal of Clinical Oncology. 2022 Oct 10
• 4 citations
  Modeling the Cost-Effectiveness of Adjuvant Osimertinib for Patients with Resected EGFR-mutant Non-Small Cell Lung Cancer.
  Christopher A Lemmon, Emily C Zabor, Nathan A Pennell> ;The Oncologist. 2022 May 6
• Response to: Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalum...
  Vidya Sankar Viswanathan, Mohammadhadi Khorrami, Khalid Jazieh, Pingfu Fu, Nathan Pennell, Anant Madabhushi> ;Journal for Immunotherapy of Cancer. 2022 May 1
• 4 citations
  Impact of Workforce Challenges and Funds Flow on Cancer Clinical Trial Development and Conduct.
  Nathan A Pennell, Connie Szczepanek, David Spigel, Suresh S Ramalingam> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2022 Apr 1
• 21 citations
  Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab.
  Khalid Jazieh, Mohammadhadi Khorrami, Anas Saad, Mohamed Gad, Amit Gupta, Pradnya Patil, Vidya Sankar Viswanathan, Prabhakar Rajiah, Charles J Nock, Michael Gilkey, Pi...> ;Journal for Immunotherapy of Cancer. 2022 Mar 1
• 5 citations
  Chemoimmunotherapy for EGFR-Mutant NSCLC: Still No Clear Answer.
  Bharathi Muthusamy, Nathan Pennell> ;Journal of Thoracic Oncology. 2022 Feb 1
• Author Correction: Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases.
  Adam Lauko, Bicky Thapa, Mayur Sharma, Baha'eddin A Muhsen, Addison Barnett, Yasmeen Rauf, Hamid Borghei-Razavi, Vineeth Tatineni, Pradnya Patil, Alireza Mohammadi, Sa...> ;Scientific Reports. 2022 Jan 18
• Author Correction: Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases.
  Adam Lauko, Rupesh Kotecha, Addison Barnett, Hong Li, Vineeth Tatineni, Assad Ali, Pradnya Patil, Alireza M Mohammadi, Samuel T Chao, Erin S Murphy, Lilyana Angelov, J...> ;Scientific Reports. 2022 Jan 17
• 5 citations
  Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States.
  Jessica E Hawley, Tianyi Sun, David D Chism, Narjust Duma, Julie C Fu, Na Tosha N Gatson, Sanjay Mishra, Ryan H Nguyen, Sonya A Reid, Oscar K Serrano, Sunny R K Singh,...> ;JAMA Network Open. 2022 Jan 4
• Optimal predictive probability designs for randomized biomarker-guided oncology trials.
  Emily C Zabor, Alexander M Kaizer, Nathan A Pennell, Brian P Hobbs> ;Frontiers in Oncology. 2022 Jan 1
• Join now to see all

Journal Articles

• Adjuvant Targeted Therapy for Patients with Epidermal Growth Factor Receptor–Mutant Lung Cancer  
  Nathan Pennell, MD, JAMA Oncology
• ALK Status Testing in Non-small Cell Lung Carcinoma by FISH on ThinPrep Slides with Cytology Material  
  Minca EC, Lanigan C, Reynolds JP, Wang Z, Ma PC, Cicenia J, Almeida FA, Pennell NA, Tubbs RR, J Thor Onc, 1/1/2014
• High MET Receptor Expression but not Gene Amplification in ALK 2p23 Rearrangement Positive Non-Small Cell Lung Cancer  
  Feng Y, Minca EC, Lanigan C, Liu A, Zhang W, Yin L, Pennell NA, Farver C, Tubbs R, Ma PC, J Thor Onc, 1/1/2014
• (The Cancer Genome Atlas Network) Comprehensive Molecular Profiling of Lung Adenocarcinoma  
  Meyerson M, Collisson E, et al., Nature, 1/1/2014
• RET-Rearranged Lung Adenocarcinomas with Lymphangitic Spread, Psammoma Bodies, and Clinical Responses to Cabozantinib  
  Mukhopadhyay S, Pennell NA, Ma PM, Ali SM, Ross JS, Velcheti V, J Thor Onc, 1/1/2014
• EGFR Mutational Genotyping of Liquid Based Cytology Samples Obtained via Fine Needle Aspiration (FNA) at Endobronchial Ultrasound Guided Fine Needle Aspiration of Non-...  
  Tubbs RR, Minca E, MacNamarra S, Reynolds J, Almeida F, Ma P, Pennell N, Cicenia J, Lung Cancer, 1/1/2014
• A Stereotactic Body Radiotherapy-Based Treatment Model for Stage I Medically Inoperable Small Cell lung Cancer  
  Videtic GM, Stephans KL, Woody NM, Pennell NA, Shapiro M, Reddy CA, Djemil T, Practical Radiation Oncology, 1/1/2013
• EGFR Molecular Testing in African-American Non-Small Cell Lung Cancer Patients - A Review of Discrepant Data  
  Clifford BT, Fu P, Pennell NA, Halmos B, Leidner RS, Trans Lung Cancer Res, 1/1/2013
• ALK Gene Rearrangement Testing in Non-small Cell Lung Carcinoma: Correlation between Ultrasensitive IHC and FISH  
  Minca EC, Portier BP, Wang Z, Lanigan C, Farver C, Feng Y, Ma PC, Arrossi V, Pennell N, Tubbs RR, J Mol Diagn, 1/1/2013
• ZEPHYR Illustrates the Perils of Testing Targeted Treatments in Unselected Non-Small-Cell Lung Cancer Patients  
  Bagai, R. and Pennell, N.A., Trans Lung Cancer Res, 1/1/2013
• XL647, a Multi-Targeted Tyrosine Kinase Inhibitor: Results of a Phase II Study in Subjects with Non-Small Cell Lung Cancer who have Progressed after Responding to Tre...  
  Pietanza MC, Lynch TJ, Lara PN, Cho J, Yanagihara RH, Vrindavanam N, Chowhan N, Gadgeel SM, Pennell NA, Funke R, Mitchell B, Wakalee HA, and Miller VA., J Thor Onc, 1/1/2012
• Superior Vena Cava Syndrome  
  Pennell, N., 1/1/2012
• Selection of Chemotherapy for Patients with Advanced Non-small Cell Lung Cancer  
  Pennell, N.A., Cleveland Clinic Journal of Medicine, 1/1/2012
• Treating ALK+ Lung Cancer in the Weeks after the FDA Approval of Crizotinib  
  Pennell, N.A., Journal of Oncology Practice, 1/1/2012
• Treating Acquired Resistance to EGFR-tyrosine Kinase Inhibitors: Still a Work in Progress  
  Pennell, N.A., Trans Lung Cancer Res, 1/1/2012
• Advanced Non-Small Cell Lung Cancer (NSCLC): Maintenance Therapy For All?  
  Hashemi-Sadraei, N. and Pennell, N.A., Curr Treat Options Oncol, 1/1/2012
• Superior Vena Cava Syndrome in Lung Cancer  
  Feng, Y. and Pennell, N.A., Lung Cancer Management, 1/1/2012
• Perspective on Kratz JR et al Lancet 2012  
  Pennell, N.A., HemOnc Today, 1/1/2012
• Expert Insight on Tsuchiya et al, Clinical Lung Cancer 2012  
  Pennell, N.A., Clinical Oncology News, 1/1/2012
• Two Generations of Light/Never-smokers with Advanced Adenocarcinoma of the Lung with Durable Responses to Erlotinib  
  Pennell, N. A., Yin, L., Keshtgarpour, M., and Ma, P.C., J Thor Onc, 1/1/2012
• Integration of EGFR Inhibitors and Conventional Chemotherapy in the Treatment of NSCLC  
  Pennell, N.A., Clin Lung Cancer, 1/1/2011
• Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non-Small Cell Lung Cancer  
  Zhu, C., Ding, K., Strumpf, D., Weir, B.A., Meyerson, M., Naoki, K., Pennell, N., Ladd-Acosta, C., Thomas, R.K., Liu, N., Pintilie, M., Der, S., Seymour, L., Jurisica1..., J Clin Onc, 1/1/2010
• Targeting Angiogenesis in Non-Small Cell Lung Cancer: Agents in Practice and Clinical Development  
  Barzi, A. and Pennell, N.A., European Journal of Clinical & Medical Oncology, 1/1/2010
• BAC: Time to Move beyond Clinical and Pathologic Classification  
  Pennell, N.A. and Govindan, R, Oncology (Williston Park), 1/1/2010
• Phase I Study of the c-raf-1 Antisense Oligonucleotide ISIS 5132 in Combination with Carboplatin and Paclitaxel in Patients with Previously Untreated, Advanced Non-Sma...  
  Fidias, P., Pennell, N.A., Boral, A.L., Shapiro, G.I., Skarin, A.T., Eder, J.P., Kwoh, T.J., Geary, R.S., Johnson, B.E., Lynch, T.J., Supko, J.G., J Thor Onc, 1/1/2009
• Join now to see all

Books/Book Chapters

• IASLC Multidisciplinary Approach to Thoracic Oncology 
  Chapter: The Role of Palliative Care in Lung Cancer 
  Davis, M and Pennell, NA.LWW, NY2014

Abstracts/Posters

• Molecular Subtyping to Predict Risk of Venous Thromboembolism in Patients with Advanced Lung Adenocarcinoma: A Cohort Study
  Nathan A Pennell, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• EGFR Mutational Analysis by Allele Specific PCR on Fine Needle Aspiration and Biopsy Derived Samples of Non-Small Cell Lung Carcinoma
  Minca EC, Brainard J, MacNamara S, Farver C, Ma PC, Arrossi V, Pennell N, Tubbs RR, USCAP Annual Meeting, 1/1/2014
• Circulating Tumor Cells Enrichment and Characterization in ALK-translocation Positive Lung Cancer
  PC Ma, L Yin, P Joshi, Y Feng, B Jacobs, W Zhang, M Shapiro, M McNamara, N Hashemi Sadraei, N Pennell, E B, M Zborowski, Proc Amer Soc Clin Onc, 1/1/2014
• Treatment (Trmt) Outcome in Lung Transplant (LTx) Recipients Who Develop Lung Cancer (LC): A Cleveland Clinic (CC) Experience
  L Du, NA Pennell, P Elson, N Hashemi, Proc Amer Soc Clin Onc, 1/1/2014
• SELECT: A Multicenter Phase II Trial of Adjuvant Erlotinib in Resected Early-stage EGFR Mutation-positive NSCLC
  NA Pennell, JW Neal, JE Chaft, CG Azzoli, PA Janne, R Govindan, TL Evans, DB Costa, RPG Rosovsky, HA Wakelee, R Suk Heist, AT Shaw, JS Temel, MA Shapiro, A Muzikansky,..., Proc Amer Soc Clin Onc, 1/1/2014
• A Study of Hsp90 Inhibitor AT13387 Alone and in Combination with Crizotinib (CZT) in the Treatment of Non-Small Cell Lung Cancer (NSCLC).
  B Besse, E Bertino, NA Pennell, A Wozniak, D Mahadevan, A Spira, A Oganesian, L Manlapaz-Espiritu, H Keer, J-C Soria, DR Camidge, ESMO, 1/1/2014
• Clinical Implications of Routine Testing for Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Nonsquamous Non-small Cell Lung Cancer (NSCLC).
  Zhu H, Arrossi AV, Elson P, Farver C, Tubbs R, Murthy S, Mason D, Mazzone P, Pennell NA, Proc Amer Soc Clin Onc, 1/1/2013
• Dowlati. Erlotinib beyond Progression Study: Randomized Phase II Study Comparing Chemotherapy plus Erlotinib with Chemotherapy Alone in EGFR Tyrosine Kinase Inhibitor ...
  B. Halmos, N.A. Pennell, G.A. Otterson, S.M. Gadgeel, T. Mekhail, M.R. Snell, J.P. Kuebler, P. Fu, N. Sharma, A., Proc Amer Soc Clin Onc, 1/1/2013
• The SELECT Study: A Multicenter Phase II Trial of Adjuvant Erlotinib in Resected Epidermal Growth Factor Receptor (EGFR) Mutation-positive Non-small Cell Lung Cancer (...
  JW Neal, NA Pennell, R Govindan, M Lanuti, R Rosovsky, R Suk Heist, AT Shaw, JS Temel, A Muzikansky, PA Janne, TJ Lynch, CG Azzoli, LV Sequist, Proc Amer Soc Clin Onc, 1/1/2012
• The Impact of Bevacizumab on the Occurrence and Recurrence of Intracranial Brain Metastases in Non-small Cell Lung Cancer (NSCLC) Patients
  ME Salem, N Szerlip, NA Pennell, KB Ali, D Altshuler, S Taylor, A Hallock, A Sukari, SM Gadgeel, AJ Wozniak, Proc Amer Soc Clin Onc, 1/1/2012
• Dowlati. Final Report of an Open-Label Phase II Trial of Bevacizumab Plus Docetaxel and Gemcitabine in Metastatic, Previously Untreated Non-squamous Non-small Cell Lun...
  N. A. Pennell, S. R. Kalmadi, M. Shapiro, H. Daw, C. Rodriguez, A. Haddad, J. Samsa, P. Elson, P. Ma, A., ASTRO/IASLC Multidisciplinary Symposium in Thoracic Oncology, 1/1/2012
• Clinical Profile and Molecular Detection of ALK 2p23 Fusion Driven Lung Cancer at Cleveland Clinic
  Y. Feng, L. Yin, J. Samsa, C. Lanigan, E. Borden, A. Arrossi, C. Farver, N. Pennell, R. Tubbs, P. C. Ma., ASTRO/IASLC Multidisciplinary Symposium in Thoracic Oncology, 1/1/2012
• Erlotinib beyond Progression Study: Randomized Phase II Study Comparing Chemotherapy plus Erlotinib with Chemotherapy Alone in EGFR TKI-responsive, Advanced Non-small ...
  B. Halmos, P. Fu, N. A. Pennell, G. A. Otterson, T. Mekhail, M. R. Snell, J. P. Kuebler, S. M. Gadgeel, A. Conrad, A. T. Stefanski, A. Dowlati., Proc Amer Soc Clin Onc, 1/1/2011
• Phase II Trial of Carboplatin, Abraxane, and Bevacizumab in NSCLC
  RS Heist, DG Duda, DV Sahani, M Ancukiewicz, P Fidias, LV Sequist, A Shaw, J Temel, I Lennes, J Neal, N Pennell, TJ Lynch, JA Engelman, RK Jain, Proc Amer Soc Clin Onc, 1/1/2011
• Pilot Study to Measure Circulating Endothelial Cells (CECs) in Patients with Non-small Cell Lung Cancer (NSCLC).
  Pennell NA, Hashemi Sadraei N, Samsa J, Henderson L, Grane R, Borden E, World Conf on Lung Cancer, Amsterdam, 1/1/2011
• ERCC1 Protein Expression Is Not Associated with Survival after Platinum-based Chemotherapy in Patients with Metastatic Non-small Cell Lung Cancer (NSCLC).
  Pennell, N.A., Chireac, L., El Karak, F., Lynch, T.J., Heist, R.S., Christiani, D.C., ERCC1 Protein Expression Is Not Associated with Survival after Platinum-based Chemotherapy in Patients with Metastatic Non-small Cell Lung Cancer (NSCLC)., 1/1/2010
• A Multicenter Phase II Trial of Adjuvant Erlotinib in Patients with Resected Non-small Cell Lung Cancer (NSCLC) And Mutations in the Epidermal Growth Factor Receptor (...
  Neal, J.W.; Pennell, N.A.; Goodgame, B.W.; Lanuti, M.; Heist, R.S.; Shaw, A.T.; Temel, J.S.; Janne, P.A.; Azzoli, C.G.; Sequist, L.V., Proc Amer Soc Clin Onc, 1/1/2010
• In Vivo Assessment of the Effects of Bevacizumab in Advanced Non-small Cell Lung Cancer (NSCLC).
  R. S. Heist, G. D. Duda, D. Sahani, N. A. Pennell, J. W. Neal, M. Ancukiewicz, J. A. Engelman, T. J. Lynch, R. K. Jain., Proc Amer Soc Clin Onc, 1/1/2010
• A Phase I/II Trial of Perioperative Paclitaxel (P), Carboplatin (C) And Erlotinib (E) With Concurrent Accelerated Hyperfractionated Radiation (HFRT) Followed by Mainte...
  Pennell, N.A., Videtic, G.M., Murthy, S., Mason, D., Rice, T.W., Mazzone, P., Samsa, J., Rich, T., Shapiro, M., Mekhail, T., Proc Amer Soc Clin Onc, 1/1/2009
• The Serial Effects of Multimodality Therapy for Stage III Non-small Cell Carcinoma on Lung Function
  Mazzone, P.J., Videtic, G., Murthy, S., Mason, D., Rice, T., Pennell, N., Rich, T., Machuzak, M., Mekhail, T., Proc Amer Soc Clin Onc, 1/1/2009
• Patient Compliance with Prolonged Erlotinib (E) Treatment: Experience from a Phase I/II Trial of Perioperative Concurrent Chemoradiotherapy (CRT) And E Followed by 2 Y...
  Pennell, N.A., Videtic, G.M., Murthy, S., Mason, D., Rice, T.W., Mazzone, P., Samsa, J., Rich, T., Shapiro, M., Mekhail, T., 13th World Lung Conference, 1/1/2009
• A Phase II Trial of the Dual Farnesyl Transferase and Geranylgeranyl Transferase Inhibitor L-778,123 in Previously Untreated Patients with Advanced Non-small Cell Lung...
  Pennell, N.A., Johnson, B., Moore, M.R., Garcia, M., Aisner, J., Pramanik, B., Morrison, B., Lynch, T.J., IASLC 7th Annual Targeted Therapies of the Treatment of Lung Cancer, 1/1/2007
• Join now to see all

Lectures

• Guidelines, Barriers, Access to Molecular Testing in NSCLC 
  ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
• Assessment and Diagnostics of Newly Diagnosed Patients With Advanced Non-Small Cell Lung Cancer 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018
• Circulating Tumor Cells Detection and Molecular Characterization of ALK(2p23)-Fusion Non-Small Cell Lung Cancer 
  Sydney - 1/1/2013
• Management of Stage III Non-small Cell Lung Cancer 
  Dana Farber Cancer Institute, Boston, MA - 1/1/2008
• Palliative Treatment for Advanced NSCLC 
  The Gathering Place, Beachwood, OH - 1/1./2013
• Molecular Testing in NSCLC: How Soon is Now? 
  Chicago, IL - 1/2./2013
• Treating Patients with Common Molecular Subtypes of NSCLC in 2013 
  Cleveland, OH - 1/27/2013
• The New Landscape for Targeted Agents in NSCLC 
  Northside Hospital, Youngstown, OH - 1/1./2013
• Management of Advanced NSCLC 
  Alliance, OH - 1/1./2014
• Use of Off-targeted Therapies in Targeted Populations 
  Boston, MA - 1/6./2014
• Lung Cancer End of the Year Review 
  NY, NY - 1/11/2014
• New Agents and Clinical Strategies in the Management of NSCLC - Research to Practice 
  Novant Health, Winston-Salem, NC, 2014; White Plains, NY, 2014 - 1/19/2014
• Malignant Mesothelioma: Non-surgical Options 
  Cleveland, OH - 1/18/2009
• Targeting the Epidermal Growth Factor Receptor in Non-small Cell Lung Cancer 
  Cleveland, OH - 1/8./2009
• Lung Cancer Update 2009 
  Rocky River, OH - 1/5./2009
• Impact of Histology on Response and Patient Selection 
  Washington, DC - 1/10/2009
• Advances in Chemotherapy for Non-small Cell Lung Cancer 
  1/29/2010
• Circulating Tumor Cells (CTCs) and Circulating Endothelial Cells (CECs) in Patients with Lung Cancer 
  1/8./2011
• Lung Cancer: Updates on Chemotherapy and Targeted Treatments 
  Westlake, OH - 1/6./2011
• Selection of Chemotherapy for Patients with Advanced NSCLC 
  Cleveland, OH - 1/30/2011
• Clinical Management: Chemotherapy in NSCLC 
  Cleveland Clinic Florida, Weston, FL - 1/8./2011
• Advances: EGFR/ALK and Lung Cancer 
  Key Largo, Florida - 1/24/2012
• Lung Cancer: Molecular Findings and Targeted Therapies 
  Boston, MA - 1/4./2012
• Update on Lung Cancer in 2012 
  Akron General Hospital, Akron, OH - 1/7./2012
• Join now to see all

Other

• Treatment of a Patient with Metastatic Non-Small-Cell Lung Cancer and Adenocarcinoma Histology 
  Pennell, N.A. and Perez-Soler, R., Oncology Consultations
  http://www.cancerlearning.com/index.cfm/fuseaction/publication.showOverview/id/9/publication_id/330
  1/1/2009
• Study Guide for "Voices from the Lived World of Illness", an Interactive DVD about Terminal Cancer Patients Created by the Institute of Medical Humanism 
  Schapira, L., Pennell, N.A., Bandman, B.M., Bandman, C.
  Burlington, VT - 1/1/2006